US 7884091
Methods for treating delirium using glucocorticoid receptor-specific antagonists
granted A61KA61K31/47A61K31/573
Quick answer
US patent 7884091 (Methods for treating delirium using glucocorticoid receptor-specific antagonists) held by Corcept Therapeutics Incorporated expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/47, A61K31/573